
19/06/2025
We've been quiet on social media, however there is lots of work behind the scenes at VAS currently. The start of the equine sporting season gives us chance to catch a breath on the equine side, but its been truly joyful to follow the season and see some past patients out back competing at the top of their game. It brings back the very reason that VAS was set up for after founder Jenny felt that there was no place to turn for a "course" of prp with known content, which she felt she wanted to access for her own event horse with a stifle injury. It takes a huge team effort to treat these horses of which we feel truly privileged to have been a part.
This has meant some extra time in small animal clinic and a focus on canines for a while. We've treated a wide variety of patients from apheresis treatment of racing greyhounds with tendon injuries to treatment of early onset elbow and shoulder djd in cockapoos via our ESTAR tropovet technology for smaller patients. All are doing well and we look forward to following their progress.
Then the most exciting update thanks to the support and interest from Emily Clarke, a researcher at Liverpool University after we met at BEVA last year, alongside the trust and generosity of some of our past patients has been planning the study and obtaining consent for surplus sample inclusion so we can truly look to put more detailed data into our service. We already record whole blood and prp platelet, white cell and red cell content, so every patient gets a bespoke result and recommendation for treatment volumes and regimes, however extracellular vesicles are of current interest in the regenerative medicine field and have been researched recently particularly in reference to preserved PRP and stem cell activity. Real data as to the EV content of autologous PRP is often not known as the PRP is used at the time, requires specialist testing and is not analysed. We intend to change that for our offering and very much look forward to putting these numbers into the developement of our service longer term, and bring to the forefront a true understandng of frozen prp content and its place in the biologics catalogue.